Nephros Q4 2023 GAAP EPS $(0.060) Misses $(0.030) Estimate, Sales $3.300M Miss $3.813M Estimate
Portfolio Pulse from Benzinga Newsdesk
Nephros reported Q4 2023 GAAP EPS of $(0.060), missing the $(0.030) estimate, with sales of $3.300M also missing the $3.813M estimate. This represents a 29.01% increase over the same period last year.
March 07, 2024 | 9:42 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Nephros missed Q4 2023 earnings and sales estimates, with a significant increase in sales compared to last year.
Missing both earnings and sales estimates typically has a negative short-term impact on a company's stock price. However, the significant year-over-year sales increase may mitigate some negative perceptions.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100